Pag-aaral pangklinika para sa Katarata sa Texas
7 pag-aaral para sa Katarata ang naghahanap ng mga kalahok sa mga site sa Texas.
Mga Lungsod sa Texas
Opisyal na teksto ng pag-aaral (English)
A Prospective, Randomized, Subject and Vision-assessor Masked, Multicenter Study Comparing Bilateral Clareon PanOptix, Bilateral Clareon PanOptix Pro, and Mixed Clareon PanOptix Pro/Vivity Intraocular Lens Implantation in Cataract Subjects
- Berkeley Eye Center, Houston
Nagre-recruitPhase 4Malugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Set 30, 2026 · NCT06922084A Prospective, Randomized, Subject- and Examiner-Masked, Multicenter Study Comparing Bilateral Clareon TruPlus and Bilateral Clareon Monofocal Intraocular Lens Implantation (Spherical and Toric) in Cataract Subjects
- Berkeley Eye Center - Sugar Land, Sugar Land
Nagre-recruitPhase 4
Edad 22 pataas · Lahat ng kasarian · Na-update Hul 21, 2026 · NCT07693205Clareon TruPlus Study
- Berkeley Eye Center, Sugar Land
Nagre-recruit
Edad 22 pataas · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT07502456IC-8 Apthera IOL New Enrollment Post Approval Study
- Berkeley Eye Center, Sugar Land
Nagre-recruitObservasyonal na pag-aaral
Edad 22 pataas · Lahat ng kasarian · Na-update Ene 12, 2026 · NCT06060041Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
- R and R Eye Research, LLC, San Antonio
Nagre-recruitPhase 3
Edad 22 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT07218796Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
- Houston Eye Associates, Houston
Nagre-recruitPhase 3
Edad 22 pataas · Lahat ng kasarian · Na-update Okt 20, 2025 · NCT07218783Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
- Methodist Eye Associates | Houston Methodist, Houston
Nagre-recruit
Edad 65 pataas · Lahat ng kasarian · Na-update Dis 3, 2024 · NCT05438732Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.